Advancing the Massachusetts Innovation Economy: A Policy Whitepaper on Rectifying the S-Corporation Research and Development Tax Credit Exclusion

1. Executive Summary

Massachusetts has long positioned itself as a global leader in the knowledge economy, leveraging its concentration of elite academic institutions, a sophisticated labor force, and a robust venture capital ecosystem to drive breakthroughs in life sciences, software, and advanced manufacturing. Central to this success is the Research and Development (R&D) Tax Credit, established under Massachusetts General Laws Chapter 63, Section 38M. This incentive is designed to alleviate the financial risks inherent in innovation by providing a dollar-for-dollar reduction in corporate excise liability for qualified research conducted within the Commonwealth.

However, a significant structural misalignment exists within the current tax framework that disproportionately impacts small to medium-sized businesses (SMBs). While the state provides a mechanism for corporations to claim these credits at the entity level, it explicitly denies the “flow-through” of these credits to the individual shareholders of S-corporations—a common entity structure for burgeoning startups and family-owned innovation firms.

This exclusion creates a scenario where S-corporations generate substantial credits that they cannot effectively utilize because their entity-level excise tax is often minimal, while their shareholders—who bear the primary tax burden on the company’s income—are prohibited from using the credits to offset their personal income tax liabilities under Chapter 62. This policy report analyzes the mechanics of this exclusion, examines its impact on the Massachusetts innovation pipeline, and proposes two legislative solutions: the direct harmonization of S-corporation flow-through provisions with the existing partnership model, and the integration of R&D credits into the elective Pass-Through Entity (PTE) Excise framework established under Chapter 63D. By addressing this disparity, the Commonwealth can unlock vital capital for local innovators, ensure tax equity across different business structures, and maintain its competitive edge against peer states that already offer more flexible credit utilization for pass-through entities.

2. The Framework of the Massachusetts Research and Development Tax Credit

The Massachusetts Research Credit is intended to stimulate private sector investment in scientific and technological advancement. In large part, the state credit is modeled after the federal research credit allowed under Internal Revenue Code (IRC) Section 41. To qualify for the credit, a business must perform qualified research activities in Massachusetts that meet the IRS “Four-Part Test”: the research must be intended to develop a new or improved business component; it must be technological in nature, relying on physical, biological, or computer sciences; it must aim to eliminate uncertainty regarding the capability, method, or design of a product or process; and it must involve a process of experimentation.

Calculation Methodologies and Statutory Limits

Since 2015, the Commonwealth has offered two primary methods for calculating the credit, allowing taxpayers to choose the approach that best suits their financial history and growth trajectory. The first is the Traditional Method, which provides a credit of 10% for expenses exceeding a “base amount” tied to historical gross receipts. The second is the Alternative Simplified Method (ASM), which compares current-year spending to a three-year rolling average.

Table 1: Comparison of Calculation Methodologies

The utilization of the credit is governed by strict limitations under M.G.L. c. 63, § 38M. A corporation cannot reduce its excise tax liability below the statutory minimum of $456. Furthermore, the credit is limited to 100% of the first $25,000 of excise tax due, plus 75% of any excise liability exceeding that threshold. While unused credits can be carried forward for 15 years, credits disallowed specifically by the 75% rule may be carried forward indefinitely.

Eligible Expenses in the Massachusetts Context

To be eligible for the Massachusetts credit, the research must be conducted physically within the Commonwealth. This geographic restriction ensures that the tax expenditure directly benefits the local labor market and industrial base. Qualified research expenses (QREs) generally fall into three categories: wages paid to employees directly involved in or supporting research; supplies and materials consumed during experimentation (excluding depreciable property); and a portion of payments made to third-party contractors.

Table 2: Verification of Eligible Expenses

3. The Policy Issue: The Exclusion of S-Corporation Shareholders

The primary conflict in the Massachusetts R&D tax credit framework arises from the intersection of corporate excise law (Chapter 63) and personal income tax law (Chapter 62). S-corporations are unique in that they are “pass-through” entities for federal and most state purposes, meaning their income is taxed once at the shareholder level rather than twice at both the corporate and individual levels. However, Massachusetts imposes a “hybrid” tax treatment on S-corporations.

The Mechanism of Disparity

Under M.G.L. c. 63, § 38M(b) and the Department of Revenue (DOR) regulation 830 CMR 63.38M.2, an S-corporation is allowed to claim the R&D credit against its own corporate excise liability. This excise consists of two measures: an income measure (for larger S-corps) and a non-income measure based on property or net worth. For many small innovation firms that have not yet reached significant profitability or that operate primarily as service businesses with few physical assets, this entity-level excise is negligible.

The critical failure in the current policy is that any excess credit generated by the S-corporation cannot flow through to its shareholders. This stands in stark contrast to the treatment of partnerships and other unincorporated entities. In a partnership, the R&D credit is attributed to the partners based on their distributive share of the business, and they may use it to offset their personal income tax liabilities under Chapter 62. Because S-corporation shareholders are subject to the same personal income tax on their share of the company’s income, the denial of the R&D credit creates a significant tax equity gap.

Economic Consequences for Massachusetts SMBs

The “S-Corp Trap” has profound implications for the growth of small and medium-sized enterprises in the state. Because these firms cannot pass the credit to shareholders, the credits often sit unused as carryforwards on the company’s books. For a startup in its early stages, the inability to utilize these credits to reduce the effective tax rate for its founders and early investors increases the “burn rate” of capital.

Table 3: Entity Structure Comparison

This disparity effectively penalizes entrepreneurs for choosing the S-corporation structure—a structure that is otherwise highly advantageous for liability protection and tax simplicity. Furthermore, as most innovative SMBs in Massachusetts are organized as S-corporations, a vast swath of the local innovation economy is functioning under a sub-optimal incentive structure compared to competitors in states with more modern pass-through rules.

4. Comparative Analysis: Regional and National Peer States

To understand the competitive disadvantage facing Massachusetts, it is necessary to examine how other innovation-heavy states handle R&D credits for pass-through entities. The national trend is toward full flow-through or enhanced refundability to ensure that small businesses have the same liquidity incentives as large C-corporations.

Pro-Innovation Models in Other Jurisdictions

Several states have implemented policies that directly address the pass-through utilization issue. These models provide a roadmap for how Massachusetts could modernize its own framework.

• Georgia: Georgia is often cited by tax practitioners as a model for SMB research incentives. In Georgia, the R&D tax credit applies to all business entities, and for pass-through entities, the credit is apportioned to shareholders for use on their personal tax returns. Crucially, if the credit exceeds the income tax liability, Georgia allows the remaining portion to be applied against the company’s payroll tax withholding, providing immediate cash flow to startups that are not yet profitable.
• California: While California’s tax system is complex, it allows a significant portion of the R&D credit to flow through to S-corporation shareholders. Typically, one-third of the credit remains at the entity level to offset the 1.5% S-corp franchise tax, while the remaining two-thirds flows through to the shareholders’ personal returns.
• New York: New York offers the Excelsior Research and Development Tax Credit, which is fully refundable and available to both corporate and personal income tax filers. This ensures that the incentive is meaningful regardless of the company’s entity structure or current tax liability.
• Connecticut: Connecticut does not allow flow-through for S-corporations but provides a critical alternative: a 65% cash refund for small businesses with credits they cannot claim due to a lack of tax liability. This provides liquidity that an indefinite carryforward cannot match.

Table 4: Multi-State S-Corp Parity Analysis

5. Proposed Solution 1: Direct Statutory Flow-Through Alignment

The most effective and legally consistent solution to the current policy issue is for the Massachusetts Legislature to amend M.G.L. c. 63, § 38M to allow for the direct flow-through of R&D credits to S-corporation shareholders. This would harmonize the treatment of S-corporations with the existing rules for partnerships and other unincorporated flow-through entities.

Legislative Implementation and Parity

By amending the language of Section 38M to specify that the credit shall be “attributed to the shareholders of an S-corporation in the same manner as partnerships,” the state would resolve the entity-choice penalty. This change would require the Department of Revenue to update the Schedule SK-1 (the Massachusetts S-corporation shareholder information form) to include a line for the allocation of the research credit.

The rationale for this change is rooted in the fact that the economic burden of R&D investment in an S-corporation is borne by the shareholders. When an S-corporation spends $100,000 on research, that expenditure reduces the distributive share of income passed through to the shareholders. Providing the tax credit to those same shareholders is a matter of basic tax symmetry. Furthermore, since the state already manages this process for partnerships, the administrative infrastructure for tracking and verifying these credits at the individual level already exists.

Benefits of Alignment

Direct alignment would provide several immediate benefits to the Massachusetts innovation ecosystem. First, it would provide an immediate liquidity boost to S-corporation founders who are often reinvesting their personal savings into their companies. Second, it would simplify tax planning for SMBs, allowing them to focus on research rather than complex entity-level tax gymnastics. Third, it would signal to the national venture capital community that Massachusetts is a competitive environment for early-stage companies that prefer pass-through structures.

6. Proposed Solution 2: Integration with the Pass-Through Entity (PTE) Excise

A second, more modern approach would be to integrate the R&D tax credit into the existing elective Pass-Through Entity (PTE) Excise framework under Chapter 63D. Massachusetts established the PTE Excise in 2021 as a mechanism for shareholders and partners to bypass the federal $10,000 cap on state and local tax (SALT) deductions.

The Mechanics of the PTE Offset

Under Chapter 63D, an S-corporation can elect to pay a 5% tax at the entity level on its income that is subject to the Massachusetts personal income tax. The shareholders then receive a 90% refundable credit on their personal returns for the tax paid by the entity. This system creates a sophisticated “bridge” between corporate and personal taxation that could be leveraged for R&D credits.

The proposed change would allow S-corporations to use their generated R&D credits to offset the 5% PTE Excise liability. This would effectively allow the company to use its “locked” R&D credits to pay the tax that its shareholders would otherwise have to pay. Because the PTE credit for shareholders is 90% refundable, this integration would ensure that the value of the R&D credit reaches the shareholders’ pockets, providing the intended financial incentive.

Synergy with the 4% Personal Income Surtax

In 2024, there has been significant legislative discussion regarding expanding the PTE Excise to include the 4% “fair share” surtax on high-income earners. Allowing R&D credits to offset this expanded excise would be a powerful retention tool. High-net-worth founders and successful serial entrepreneurs in Massachusetts would be highly incentivized to keep their research activities in the state if they could use those R&D credits to offset a portion of the surtax on their business income.

Table 5: Integration with the PTE Excise

7. Accountability: Preventing Fraud and Wastage in SMB Credits

A critical component of any tax credit expansion is ensuring that the program is not subject to abuse. In the context of S-corporations and SMBs, the risk often centers on the “reclassification” of ordinary business expenses as R&D costs to obtain a lower effective tax rate. To safeguard the Commonwealth’s finances, the government should implement a multi-layered accountability strategy.

The Pre-Certification and Award Model

Massachusetts has already developed successful models for targeted, high-accountability tax credits through the Massachusetts Life Sciences Center (MLSC) and the Massachusetts Clean Energy Center (MassCEC).

• Certification of Eligibility: The state could require S-corporations seeking flow-through R&D credits to obtain a “Small Business Innovation Certification.” This would involve a preliminary review of the company’s research goals to ensure they meet the technological and uncertainty requirements of the Four-Part Test.
• Performance-Based Benchmarks: Following the model of the Climatetech Incentive Jobs Credit, the state could tie the flow-through benefit to the retention or creation of a minimum number of full-time R&D jobs in Massachusetts. If a company fails to meet these job targets, the DOR should have the authority to “recapture” the credit from the shareholders.

Enhanced Audit Guidelines and Transparency

The DOR already possesses broad authority under AP 609 to audit tax returns and verify liabilities. For expanded S-corp credits, the following audit standards should be mandated:

• Mandatory Contemporaneous Documentation: Taxpayers must be required to maintain project-specific documentation—such as laboratory notebooks, software versioning logs, and time-tracking records—at the time the expenses are incurred. The DOR should explicitly state that “reconstructed” records created years after the fact will not be accepted during an audit.
• Disclosure of All Research Support: Following the logic of Senate Bill S2753, corporations claiming the credit should be required to disclose all sources of “current and pending research support,” including federal grants and in-kind contributions. This prevents “double-dipping” where a state tax credit is claimed for research already funded by the federal government or a non-profit foundation.
• Searchable Electronic Record Mandate: To facilitate efficient “desk audits,” the DOR should require S-corps claiming credits over a certain threshold to provide all accounting and payroll records in a searchable electronic format. This allows auditors to use statistical sampling methods to quickly verify the validity of high-volume wage claims.

Anti-Abuse Provisions for Tiered Entities

To prevent sophisticated tax avoidance schemes, the legislature must ensure that credits cannot be “trapped” or artificially inflated through tiered ownership structures. The rules should specify that the credit can only be attributed to individual shareholders who are natural persons, estates, or trusts, preventing C-corporations or other non-qualified entities from benefiting through an S-corp shell.

8. Cost Analysis and Future Economic Benefits

Expanding the flow-through of R&D credits will result in an initial reduction in tax collections for the General Fund. However, a static cost analysis (which only looks at the “loss” of revenue) fails to account for the dynamic economic benefits that innovation incentives provide. In the context of the Massachusetts budget, this change should be viewed as an investment in future tax base expansion.

The Multiplier Effect and Revenue Neutrality

Research on state-level R&D credits suggests a powerful multiplier effect. For every dollar of tax credit provided, companies typically increase their private R&D spending by approximately $1.50. This increased spending translates directly into taxable economic activity.

Table 6: Economic Multiplier Effect

Quantifying the Benefits of Innovation

An MIT study found that areas introducing R&D tax credits experience a 20% rise in “high-quality new-firm formation” over a ten-year period. In Massachusetts, where the innovation economy is a primary driver of GDP, this 20% increase represents thousands of new jobs and millions in future tax revenue. Furthermore, by providing liquidity to S-corp shareholders, the state encourages these founders to “recycle” their capital into new Massachusetts-based ventures once their current company is acquired or goes public, creating a self-sustaining innovation loop.

The Cost of Inaction: “Innovation Leakage”

The “cost” of the policy change must be weighed against the cost of doing nothing. If Massachusetts remains an outlier with its restrictive S-corp rules, it faces two primary fiscal risks:

• Firm Flight: Mobile startups in software and fintech may choose to incorporate or relocate to Georgia, New York, or California where their R&D credits are more valuable. The loss of a single successful startup can represent millions in lost future payroll and corporate taxes.
• The “Valley of Death” Mortality: Without the liquidity provided by used R&D credits, more Massachusetts startups may fail during their pre-profitability phase. Every failed startup represents a wasted investment of state resources and a loss of potential future revenue.

9. Importance of the Policy Change and Negative Consequences of Inaction

The proposed change is not merely a technical tax adjustment; it is a fundamental correction necessary to sustain the health of the Massachusetts business climate. The innovation economy is increasingly driven by small, agile teams that rely on pass-through entity structures for their flexibility and efficiency.

Protecting the “Main Street” Innovation Economy

While Massachusetts is world-renowned for its massive pharmaceutical campuses, the “Main Street” innovation economy—composed of 10-to-50 person startups in Worcester, Lowell, and Cambridge—is what provides the state with its economic resilience. These firms are currently operating at a competitive disadvantage. Rectifying the S-corp exclusion ensures that these smaller players have access to the same financial tools as their multinational counterparts, fostering a more inclusive and diverse innovation ecosystem.

Negative Consequences of Maintaining the Status Quo

If the Massachusetts Legislature does not act to resolve the S-corp shareholder exclusion, several negative outcomes are likely to accelerate:

• Erosion of Regional Competitiveness: As neighboring states like Connecticut and New York modernize their incentives, Massachusetts will appear increasingly “unfriendly” to small business owners. This sentiment can be captured in business climate rankings and “InventionIndex” scores, which influence where venture capitalists direct their portfolio companies to hire.
• Sectoral Stagnation in Non-Life Science Fields: Because the MLSC program already offers a “refundability” workaround for life sciences, the current exclusion primarily hurts sectors like robotics, clean energy, and cybersecurity. Failure to act will lead to an over-concentration in biotech, making the Massachusetts economy more vulnerable to sector-specific downturns.
• Capital Inefficiency: Billions of dollars in unused R&D tax credits will continue to sit on balance sheets as worthless carryforwards. This is an inefficient use of a state-sanctioned incentive. A tax credit that cannot be used is not an incentive; it is a hollow promise that does nothing to drive current-year research activities.

10. Conclusion

The exclusion of S-corporation shareholders from the Massachusetts Research and Development tax credit represents a significant missed opportunity for the Commonwealth. By maintaining a framework that prevents small business owners from utilizing the credits they have earned, the state is effectively taxing innovation at a higher rate for its most vulnerable firms.

The implementation of a flow-through mechanism—either through direct statutory alignment or integration with the PTE Excise—is a practical and fiscally sound solution. These changes, when paired with the rigorous accountability standards already practiced by the Department of Revenue, would provide an immediate and powerful stimulus to the Massachusetts startup ecosystem. The economic evidence suggests that the resulting increase in high-quality firm formation, high-wage job creation, and private investment will more than compensate for the initial tax expenditure. To maintain its status as the “State of Innovation,” Massachusetts must ensure that its tax policies are as innovative and forward-thinking as the businesses it seeks to attract and retain.